Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Hooda

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
The American Journal of Cardiology|January 7, 2026
Procedural Complexity and Bleeding Risk in Patients Undergoing Percutaneous Coronary InterventionRidhima Goel, Alessandro Spirito, Davide Cao, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 7, 2025
Long-term clinical outcomes of intravascular brachytherapy for multilayer drug-eluting in-stent restenosisRichard Tanner, Vishal Dhulipala, Udit Joshi, et al.
The American Journal of Cardiology|May 2, 2024
Impact of Polyvascular Disease in Patients Undergoing Unprotected Left Main Percutaneous Coronary InterventionBenjamin Bay, Raman Sharma, Anastasios Roumeliotis, et al.
JACC. Cardiovascular Interventions|May 10, 2023
Validation of UK-BCIS CHIP Score to Predict 1-Year Outcomes in a Contemporary United States PopulationGaurav Khandelwal, Alessandro Spirito, Richard Tanner, et al.
The American Journal of Cardiology|April 24, 2025
Inflammation and Contrast-Associated Acute Kidney Injury in Patients Undergoing Percutaneous Coronary InterventionMark Shneyderman, Johny Nicolas, Samantha Sartori, et al.
European Heart Journal|June 1, 2026
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2025
Impact of lesion location and SYNTAX score breakdown on patients undergoing percutaneous left main revascularizationAnastasios Roumeliotis, David Power, Samantha Sartori, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 20, 2023
Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromesAnoop N Koshy, Gennaro Giustino, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|November 24, 2022
Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary InterventionAnoop N Koshy, Gennaro Giustino, Samantha Sartori, et al.
Atherosclerosis|June 30, 2026
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-studyPruthvi C Revaiah, Yuliya Vengrenyuk, Vemuri Krishna Santosh, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
The American Journal of Cardiology|January 7, 2026
Procedural Complexity and Bleeding Risk in Patients Undergoing Percutaneous Coronary InterventionRidhima Goel, Alessandro Spirito, Davide Cao, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 7, 2025
Long-term clinical outcomes of intravascular brachytherapy for multilayer drug-eluting in-stent restenosisRichard Tanner, Vishal Dhulipala, Udit Joshi, et al.
The American Journal of Cardiology|May 2, 2024
Impact of Polyvascular Disease in Patients Undergoing Unprotected Left Main Percutaneous Coronary InterventionBenjamin Bay, Raman Sharma, Anastasios Roumeliotis, et al.
JACC. Cardiovascular Interventions|May 10, 2023
Validation of UK-BCIS CHIP Score to Predict 1-Year Outcomes in a Contemporary United States PopulationGaurav Khandelwal, Alessandro Spirito, Richard Tanner, et al.
The American Journal of Cardiology|April 24, 2025
Inflammation and Contrast-Associated Acute Kidney Injury in Patients Undergoing Percutaneous Coronary InterventionMark Shneyderman, Johny Nicolas, Samantha Sartori, et al.
European Heart Journal|June 1, 2026
Standard modifiable risk factors among patients undergoing percutaneous coronary intervention: prevalence and impactJohny Nicolas, Angelo Oliva, Rebecca Cohen, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 1, 2025
Impact of lesion location and SYNTAX score breakdown on patients undergoing percutaneous left main revascularizationAnastasios Roumeliotis, David Power, Samantha Sartori, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 20, 2023
Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromesAnoop N Koshy, Gennaro Giustino, Samantha Sartori, et al.
JACC. Cardiovascular Interventions|November 24, 2022
Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary InterventionAnoop N Koshy, Gennaro Giustino, Samantha Sartori, et al.
Atherosclerosis|June 30, 2026
Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-studyPruthvi C Revaiah, Yuliya Vengrenyuk, Vemuri Krishna Santosh, et al.
Pageof 8